Extrapleural Intercostal Catheter vs. Thoracic Epidural for Thoracotomy Pain

NCT ID: NCT00373633

Last Updated: 2014-08-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

PHASE1

Total Enrollment

26 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-09-30

Study Completion Date

2012-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

We will compare thoracic epidural anesthesia which is presently used for management of pain after thoracotomy to an intra-operatively placed extrapleural intercostal catheter. The study wil be double blinded and prospective.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim of this study is to evaluate the efficacy of thoracic epidural vs. continuous extra-pleural intercostal local anesthesia for the treatment of post thoracotomy pain in adult patients. Study patients will be randomized between the thoracic epidural and continuous extrapleural catheter groups\[Figure 1\]. Because thoracic epidural anesthesia is the gold standard but continuous extrapleural intercostal local anesthesia is potentially easier and less prone to complications, the study will be structured as an "equivalence study". The null hypothesis (Ho) is that continuous intercostal nerve blockade is worse than epidural for post-thoracotomy pain management. Therefore, the alternative hypothesis (Ha) is then that continuous intercostal nerve blockade is equal to or better than epidural for post-thoracotomy pain management.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

THoracotomy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Continuous extra-pleural intercostal local anesthesia

intra-operatively placed extrapleural intercostal catheter

Group Type EXPERIMENTAL

Extrapleural Intercostal Catheter

Intervention Type PROCEDURE

Continuous extra-pleural intercostal local anesthesia

Thoracic Epidural

gold standard

Group Type ACTIVE_COMPARATOR

Thoracic Epidural

Intervention Type PROCEDURE

Gold standard for post thoracotomy pain

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Thoracic Epidural

Gold standard for post thoracotomy pain

Intervention Type PROCEDURE

Extrapleural Intercostal Catheter

Continuous extra-pleural intercostal local anesthesia

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Unilateral thoracotomy
* Video Assisted thoracotomy with high likely hood of converting to open thoracotmoy

Exclusion Criteria

* Bilateral thoracotomy
* Planned bilateral thoracotomy
* Planned chest wall resection
* Planned combined thoracotomy and laparotomy procedure
* VATS procedure without conversion to unilateral thoracotomy
* Emergency operation
* Critically ill patients
* Patients who require an assistive device (i.e. cane, walker, or wheel chair) for mobility
* Patients who are unable to give informed consent
* Patients with preoperative chronic back or chest wall pain
* Empyema or other infective condition increasing the risk of epidural infection
* Coagulopathy
* Decision of the surgeon or anesthesiologist, or choice of the patient
* Infection at site of epidural placement
* Patients with other co morbidities which exclude thoracic epidural placement
* Patients under the age of 18 years
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

I-Flow

INDUSTRY

Sponsor Role collaborator

Virginia Commonwealth University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mark Nelson, MD

Role: PRINCIPAL_INVESTIGATOR

Virgina Commonwealth University, Dept of Anesthesia

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Virginia Commonwealth University

Richmond, Virginia, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

VCU 011906

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Ultrasound-guided PVB
NCT01842698 TERMINATED PHASE2